REVELATION BIOSCIENCES, INC. Payments for Repurchase of Redeemable Preferred Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- REVELATION BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for the quarter ending 2024-12-31 was $0.00.
- REVELATION BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for the quarter ending 2024-09-30 was $0.00.
- REVELATION BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for the quarter ending 2024-06-30 was $0.00.
- REVELATION BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- REVELATION BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- REVELATION BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for fiscal 2023 was $5.00K.
- REVELATION BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for fiscal 2022 was -$5.00K.
| Period end | Payments for Repurchase of Redeemable Preferred Stock 3 month | Payments for Repurchase of Redeemable Preferred Stock 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2025-03-06 |
| 2024-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-09-23 | $0.00 derived: sum of 4 quarters · filed 2025-03-06 |
| 2024-03-31 | $0.00 10-Q/A · filed 2024-09-23 | $0.00 derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $5.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-09-23 | $0.00 derived: sum of 4 quarters · filed 2024-09-23 |
| 2023-03-31 | $5.00K 10-Q/A · filed 2024-09-23 | $0.00 derived: sum of 4 quarters · filed 2024-09-23 |
| 2022-12-31 | -$5.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | -$5.00K 10-K/A · filed 2024-09-23 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |